Medtronic, Inc. Asks Supreme Court to Overturn $74 Million Loss Against Edwards Lifesciences Corporation

Published: May 10, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Medtronic's CoreValve subsidiary asks the U.S. Supreme Court to consider its appeal of a lower court's decision to uphold a $74 million verdict in favor of Edwards Lifesciences and its Sapien heart valve. Medtronic (NYSE:MDT) wants the U.S. Supreme Court to toss a lower court's decision to uphold a $74 million win for Edwards Lifesciences (NYSE:EW) in their patent war over heart valve technology. Medtronic, which inherited the spat when it purchased CoreValve and its transcatheter aortic valve implant in April 2009 for about $700 million, filed a writ of certiorari with the Supremes this week, requesting a review of a U.S. Court of Appeals for the Federal Circuit ruling that upheld the Edwards win last November.

Help employers find you! Check out all the jobs and post your resume.

Back to news